Elevated serum leptin concentrations in women with hyperuricemia

Area of Science:

• Endocrinology
• Metabolic Health
• Cardiovascular Disease Risk Factors

Background:

• Serum uric acid is a predictor of cardiovascular disease death, particularly in women.
• Elevated serum leptin, the ob gene product, is implicated in metabolic Syndrome X.
• Metabolic Syndrome X is characterized by insulin resistance, obesity, hypertension, and dyslipidemia.

Purpose of the Study:

• To investigate the relationship between serum uric acid and serum leptin levels.
• To examine the association of uric acid with components of metabolic Syndrome X in Japanese women.

Main Methods:

• Cross-sectional study of 822 Japanese women.
• Analysis of serum uric acid levels categorized into tertiles.
• Statistical analysis including ANOVA and stepwise regression to assess relationships between variables.

Main Results:

• Higher uric acid levels correlated with increased body mass index, body fat mass, blood pressure, triglycerides, insulin resistance (HOMA-R), and leptin.
• Lower high-density lipoprotein cholesterol was observed with higher uric acid levels.
• Serum leptin remained significantly elevated in hyperuricemic women after adjusting for BMI and body fat mass, and was an independent predictor of uric acid levels.

Conclusions:

• There is an independent relationship between serum leptin and serum uric acid.
• Leptin's involvement in metabolic Syndrome X is further supported by its association with uric acid.
• These findings highlight potential therapeutic targets for managing metabolic and cardiovascular risks.